Glycemic Index of Cacao Fruit Pulp in Healthy, Human Subjects
Determination of Glycemic Index of Cacao Fruit Pulp
1 other identifier
interventional
10
1 country
1
Brief Summary
Cacao fruit pulp is a sweet and fruity carbohydrate-rich edible mucilage that is often discarded. The objective of this study is to assess the glycemic response and determine the glycemic index of cacao fruit pulp.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2023
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedMarch 6, 2024
March 1, 2024
4 months
January 12, 2024
March 4, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Plasma Glucose
Mean plasma glucose
1-120 minutes
Incremental area under the curve
Calculated from mean plasma glucose
1-120 minutes
Peak plasma glucose
Peak plasma glucose (Cmax)
1-120 minutes
Study Arms (2)
Dextrose
ACTIVE COMPARATORDextrose matched for available carbohydrate
Cacao fruit pulp
EXPERIMENTALCacao fruit pulp matched for available carbohydrate
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mars Wrigleylead
- INQUIS Clinical Researchcollaborator
Study Sites (1)
INQUIS Clinical Research
Toronto, Onterio, M5C 2N8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Wolever, MD, PhD
INQUIS Clinical Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2024
First Posted
March 6, 2024
Study Start
September 30, 2022
Primary Completion
January 24, 2023
Study Completion
May 23, 2023
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share